Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Not yet recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 57Neoplasms 40Prostatic Neoplasms 36Colorectal Neoplasms 36Carcinoma, Non-Small-Cell Lung 31Lung Neoplasms 30Pancreatic Neoplasms 21Leukemia, Myeloid, Acute 21Multiple Myeloma 17Carcinoma, Hepatocellular 15Precursor Cell Lymphoblastic Leukemia-Lymphoma 14Stomach Neoplasms 12Recurrence 12Neoplasm Metastasis 11Squamous Cell Carcinoma of Head and Neck 10Ovarian Neoplasms 10Head and Neck Neoplasms 10Glioblastoma 10Uterine Cervical Neoplasms 9Melanoma 9Carcinoma, Renal Cell 9Lymphoma, B-Cell 8Endometrial Neoplasms 8Disease 8Brain Neoplasms 8Triple Negative Breast Neoplasms 7Rectal Neoplasms 7Lymphoma, Large B-Cell, Diffuse 7Esophageal Neoplasms 7Colonic Neoplasms 7

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × Cancer Cachexia × 30 days × Clear all
NCT07584057 2026-05-13

An Phase I/IIa Clinical Study to Evaluate the Safety/Tolerability, Pharmacokinetics and Preliminary Efficacy of INB301 Injection in Patients With Cancer Cachexia

Yunnan Baiyao Group Co., Ltd.

Phase 1/2 Not yet recruiting
146 enrolled

Cancer Cachexia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡